Numerous studies have found that in the U.S., minorities such as African Americans, Hispanics and Native Americans are often underrepresented in clinical trials. Regulatory agencies and various organizations are making an effort to address this issue.

Total U.S. coronavirus cases surpassed 2 million, according to a Reuters tally, as health officials urge anyone who took part in massive protests for racial justice to get tested.

In a first-of-its-kind effort, the Biotechnology Innovation Organization (BIO) conducted a survey that attempts to dive into diversity within the pharmaceutical and biotech industry.